Posted on 7/20/20
Ambu Appoints Kellee Fitzsimmons as Tax Director
Ambu Inc., a rapidly growing medical device maker and pioneer of sterile, single-use endoscopes, has named
Posted on 7/20/20
Is Novavax Stock a Buy?
Novavax (NASDAQ:NVAX) has been dominating recent headlines. On July 7, the company announced that it had secured $1.6 billion from the White House's Operation Warp Speed . . .
Posted on 7/20/20
Better Buy: Novavax vs. Roche
Boxers of different weight classes aren't supposed to fight against each other. Lightweights shouldn't be in the ring with heavyweights. If stocks were boxers, Novavax (NASDAQ:NVAX) . . .
Posted on 7/17/20
Ambu Receives FDA Clearance for its Sterile, Single-use Duodenoscope
Ambu Inc., a rapidly growing medical device maker and pioneer of sterile, single-use endoscopes, announced today that the Ambu® aScope™ Duodeno has received 510(k) clearance from . . .
Posted on 7/17/20
Why Novavax Stock Jumped Today
What happened?Shares of Novavax (NASDAQ:NVAX) rose sharply on Thursday, ending the day up by 8.5% after the company received a couple of nods of approval from . . .
Posted on 7/16/20
Altimmune Closes $132M Public Offering
GAITHERSBURG, Md., July 16, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that its previously announced underwritten public offering of . . .
Posted on 7/16/20
Is Novavax Still a Good Coronavirus Stock to Buy?
A coronavirus vaccine candidate and billions in government-backed funding to develop it have propelled Novavax (NASDAQ:NVAX) shares around 2,300% higher this year. But with that spectacular . . .
Posted on 7/16/20
3 Reasons to Buy Novavax Stock Sooner Rather Than Later
Most investors get excited when a stock becomes a 10-bagger over several years. And why wouldn't they? Nearly everyone would react enthusiastically to multiplying an initial . . .
Posted on 7/16/20
Virginia Mason Health System Partners with Premier
CHARLOTTE, N.C.--(BUSINESS WIRE)--Virginia Mason Health System, a leading non-profit regional healthcare system serving the Pacific Northwest, and Premier Inc. (NASDAQ: PINC), a healthcare improvement company, have . . .
Posted on 7/16/20
I-Mab Announces Authorization of Stock Repurchase Program up to $20M
I-Mab (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that its Board of Directors has authorized . . .
Posted on 7/15/20
Rite Aid Expands COVID-19 Testing to 258 Total Locations
CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) will continue to expand its COVID-19 testing capacity with the addition of 161 drive-through testing locations opening on July . . .
Posted on 7/14/20
Altimmune Prices Public Offering of $115 Million of Common Stock
GAITHERSBURG, Md., July 13, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the pricing of its previously announced underwritten public . . .
Posted on 7/14/20
IPO Update: ACell Proposes $75 Million IPO Terms
SummaryACell has filed to raise $75 million from an IPO of its common stock.The firm develops and sells various wound care products.ACLL has shown strong growth . . .
Posted on 7/13/20
Altimmune Proposes Public Offering of Common Stock and Pre-Funded Warrants
GAITHERSBURG, Md., July 13, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it intends to offer and sell, subject . . .
Posted on 7/13/20
Ellicott City ER Doctor Introduces A New Device That Protects Healthcare Workers While Intubating Covid-19 Patients
When Covid-19 swept through the Northeast in April, nearly 600 healthcare workers died of the virus and thousands were infected. Now a surge in the South . . .
Posted on 7/13/20
Evolent Health Named on Best Companies for Women to Advance List 2020 by Parity.org
Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, has been named to the Parity.org . . .
Posted on 7/13/20
ACell Launches Roadshow for Initial Public Offering
ACell, Inc., a leading regenerative medicine company focused on the development, manufacture and sale of products primarily used in acute care settings as part of the . . .
Posted on 7/13/20
Cellular Biomedicine Group (CBMG) Hosts R&D Showcase and Provides Updates to Clinical Programs
Cellular Biomedicine Group, Inc. (Nasdaq: CBMG), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, provided . . .
Posted on 7/13/20
Menarini Silicon Biosystems Partners with OpGen
Menarini Silicon Biosystems (MSB), the pioneer of liquid biopsy and rare cell technologies, announced today that it has entered into a strategic co-promotion partnership for its . . .
Posted on 7/13/20
Is It Too Late to Buy Novavax Stock?
This month, the U.S. government awarded Novavax (NASDAQ:NVAX) more funding than any other company in the coronavirus vaccine race. In response, the shares surged by 32% . . .
Posted on 7/12/20
Altimmune Signs Teaming Agreement with DynPort Vaccine Company
GAITHERSBURG, Md., July 09, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it has entered into a teaming agreement . . .
Posted on 7/9/20
National Institutes of Health Federal Credit Union Announces Expanded Charter
The National Institutes of Health Federal Credit Union (NIHFCU), which marked 80 years of continued service this year, announced their new multiple common bond charter. NIHFCU’s . . .
Posted on 7/9/20
UnitedHealthcare Donates $250,000 to Nonprofits Serving Charleston, West Virginia
CHARLESTON, W.V.--(BUSINESS WIRE)--UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, is awarding $250,000 in Empowering Health grants to three community-based organizations in Charleston to expand access to . . .
Posted on 7/8/20
Why Novavax Is Outperforming Moderna
Buying momentum slowed considerably after Moderna (MRNA) shares topped $80.00. The management's timing of a stock sale worsened investor trust. Since the $87.00 peak in May . . .
Posted on 7/8/20
APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401
APEIRON Biologics AG, a private biotechnology company specializing in the discovery, development and commercialization of novel immunotherapies for cancer and respiratory diseases, and MaxCyte, Inc., a . . .

